Skip to main content
Equibles

Ikarian Capital, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1778253 DALLAS, TX
Back to IONS Full portfolio

Position in IONS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$9,539,283 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
6 quarters on record

Common Shares in IONS Over Time

Shares Held

Position Value (USD)

Derivatives in IONS

reported options exposure · as of Jun 30, 2026
CallValue
$31,716,000
CallShares
400,000
PutValue
$23,787,000
PutShares
300,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in IONS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,716,000 400,000
2026-06-30 $23,787,000 300,000
2026-03-31 $9,539,283 127,038
2026-03-31 $8,417,589 112,100
2025-12-31 $7,483,806 94,600
2025-12-31 $15,983,226 202,038
2025-09-30 $27,159,963 415,163
2025-09-30 $870,086 13,300
2021-03-31 $4,046,400 90,000
2020-12-31 $16,396,600 290,000